查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1741356

主動脈瓣狹窄市場：依類型、依主動脈瓣類型、嚴重程度、依最終用戶、地區

Aortic Stenosis Market, By Type, By Aortic Valve Types , By Severity, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

主動脈瓣狹窄市場規模預計在 2025 年達到 101.7 億美元，預計到 2032 年將達到 204.6 億美元，2025 年至 2032 年的複合年成長率為 10.5%。

分析範圍 分析詳細資訊
基準年 2024 市場規模（2025年） 101.7億美元
效能數據 2020-2024 預測期 2025-2032
預測期內的複合年成長率（2025-2032） 10.50% 預計金額（2032年） 204.6億美元

主動脈瓣狹窄是指主動脈口（分隔左心室和主動脈）變窄。它會限制血液從心臟流向主動脈，從而減少心臟主泵腔每次收縮時泵入身體的血液量。主動脈瓣狹窄會在多年內緩慢進展，早期無症狀，但隨著病情加重，症狀就會出現。隨著口徑進一步變窄，心臟必須更賣力地透過受限的口徑泵送足夠的血液，這會給心臟帶來額外的負擔。如果不及時治療，最終會削弱和損害心肌。

市場動態

高血壓、肥胖症和糖尿病等危險因子的盛行率上升對全球主動脈瓣狹窄市場的成長做出了重大貢獻。主動脈瓣狹窄的常見原因包括老齡化、主動脈瓣內鈣沉積使其變硬、風濕熱和主動脈瓣先天性畸形。預計人口老化、技術進步和認知的提高將在預測期內推動全球主動脈瓣狹窄市場的成長。此外，預計醫療保健支出的增加也將在預測期內促進全球主動脈瓣狹窄市場的成長。預計經導管主動脈瓣置換術(TAVR) 的擴展、新興市場的治療和開發新藥、個人化醫療以及遠端醫療和遠端監控將在預測期內為全球主動脈瓣狹窄市場提供成長機會。

然而，預計在預測期內，高昂的治療費用、限制性的報銷政策、可用性和意識的障礙以及臨床和程序併發症將阻礙主動脈瓣狹窄市場的成長。

本報告的主要特點

  • 本報告對全球主動脈瓣狹窄市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
  • 它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球主動脈瓣狹窄市場的主要企業是根據公司概況、產品系列、主要亮點、財務業績和策略等參數列出的。
  • 透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
  • 全球主動脈瓣狹窄市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球主動脈瓣狹窄市場的各種策略矩陣來促進他們的決策。

目錄

第1章 分析目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 人口老化
    • 醫療費用高昂
    • 經導管主動脈瓣置換術（TAVR）擴張術
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 管道分析
  • 波特五力分析
  • 企業合併（M&A）場景

4. 全球主動脈瓣狹窄市場：COVID-19感染疾病的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

第5章 全球主動脈瓣狹窄市場（依類型）（2020-2032）

  • 先天性主動脈瓣狹窄
  • 後天主動脈瓣狹窄

6. 全球主動脈瓣狹窄市場（依主動脈瓣類型分類）（2020-2032）

  • 機械主動脈瓣
  • 生物（組織瓣膜）主動脈瓣

7. 全球主動脈瓣狹窄市場依嚴重程度（2020-2032）

  • 輕度主動脈瓣狹窄
  • 中度主動脈瓣狹窄
  • 嚴重主動脈瓣狹窄

8. 全球主動脈瓣狹窄市場（依最終用戶分類）（2020-2032 年）

  • 醫院
  • 診所
  • 門診手術中心
  • 其他

9. 全球主動脈瓣狹窄市場（按地區）（2020-2032）

  • 北美洲
  • 美國
  • 加拿大
  • 雨美國
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章 競爭格局

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc
  • Braile Biomedica
  • JenaValve Technology, Inc
  • Meril Life Sciences Pvt. Ltd
  • Micro Interventional Devices, Inc
  • egnite, Inc.

第 11 章 章節

  • 分析方法
  • 關於出版商
簡介目錄
Product Code: CMI6129

Aortic Stenosis Market is estimated to be valued at USD 10.17 Bn in 2025 and is expected to reach USD 20.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 10.17 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.50% 2032 Value Projection: USD 20.46 Bn

Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.

Market Dynamics

The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve. Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.

However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the global aortic stenosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global aortic stenosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomedica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market

Aortic Stenosis Market Detailed Segmentation:

  • By Type:
    • Congenital Aortic Stenosis
    • Acquired Aortic Stenosis
  • By Aortic Valve Types:
    • Mechanical Aortic Valves
    • Bioprosthetic (Tissue) Aortic Valves
  • By Severity:
    • Mild Aortic Stenosis
    • Moderate Aortic Stenosis
    • Severe Aortic Stenosis
  • By End User:
    • Hospital
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profile:
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • Braile Biomedica
    • JenaValve Technology, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Micro Interventional Devices, Inc.
    • gnite, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Aortic Valve Types
    • Market Snapshot, By Severity
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Aging Population
    • High Cost of Treatment
    • Transcatheter Aortic Valve Replacement (TAVR) Expansion
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • Pipeline Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Aortic Stenosis Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Aortic Stenosis Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Congenital Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Acquired Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Aortic Stenosis Market, By Aortic Valve Types, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Mechanical Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Bioprosthetic (Tissue) Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Aortic Stenosis Market, By Severity, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Mild Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Moderate Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Severe Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Aortic Stenosis Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Aortic Stenosis Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2028
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • U.S.
  • Canada
  • Lain America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2028, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Edwards Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CryoLife, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • JenaValve Technology, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Meril Life Sciences Pvt. Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Micro Interventional Devices, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • egnite, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us